A novel explainable AI for revealing determinants of cancer drug response through integrative multi-omics analysis - Scorecard - MDSpire

A novel explainable AI for revealing determinants of cancer drug response through integrative multi-omics analysis

  • By

  • Shynu Padinjappurathu Gopalan

  • Vino Sundararajan

  • May 18, 2026

  • 0 min

Share

Clinical Scorecard: An Innovative Explainable AI Framework for Identifying Factors Influencing Cancer Drug Response via Integrated Multi-Omics Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsIntegration of multi-omics data and drug molecular representations (using SMILES and InChI) with explainable AI.
Target Population
Care Setting

Key Highlights

  • Clarify the clinical implications of achieving 95.87% accuracy and F1-score.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Regularly analyze drug response predictions, using metrics such as AUROC and AUPRC, and adjust treatment plans accordingly.

      Risks

        Patient & Prescribing Data

        Patients with cancer undergoing drug therapy.

        Avoid ineffective drugs and reduce unnecessary toxicity by predicting drug responses.

        Clinical Best Practices

        • Validate the model in diverse patient populations to enhance generalizability.

        Related Resources & Content

        Original Source(s)

        Related Content